|
Clinical and pathological characteristics |
|
| Number of patients |
21 |
| Pathological stage at diagnosis [n (%)] |
|
Stage II ( T2N1M0)
Stage III ( T2N2M0) |
12 (57)
9 (43) |
| Tumor size (range) (cm) |
3.4（2-5） |
| Histological type |
|
| Ductal |
21 |
| Number of invaded lymph node (range) |
8.8（1-18） |
| Estrogen receptor status [n (%)] |
|
Negative
Positive |
11（52）
10（48） |
| Progesterone receptor status [n (%)] |
|
Negative
Positive |
8（38）
13（62） |
| CerbB2 receptor status [n (%)] |
|
Negative
Positive |
9（43）
12 (57) |
